1 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow upanovimab: new trials by email Literature Review of upanovimab trials Research Report on upanovimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19 SCTA01 and SCTA01C, Placebo - COVID-19 | Phase 1 / Phase 2 | Withdrawn | Sinocelltech Ltd. | 2022-01-15 | 2022-01-27 | |
| Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects SCTA01, Placebo - Coronavirus Disease 2019(COVID-19) | Phase 1 | Completed | Sinocelltech Ltd. | 33 | 2020-07-24 | 2021-03-23 |
COVID-19 (2)
China (1)